Search results
Fighting cancer with nanoparticles: medical science hits a potential milestone
Euronews via Yahoo News· 6 days ago“The main focus of our project is to get the patient's immune system to reject the tumour,” explains...
3 52-Week-Low Losers Ready to Become Big-Time Stock Winners
InvestorPlace· 2 hours agoBottom-picking stocks to buy is one of the most difficult strategies in trading and investing. For...
How to Quit Your Elf Bar
GQ via Yahoo News· 22 hours agoSeeing some of these patients ask if they could step outside the hospital for a cigarette led Rubinstein to focus... got there.” Rubinstein describes...
Their cancers can't be cured. But new treatments are increasing the length, and quality, of their...
Milwaukee Journal Sentinel via Yahoo News· 6 days agoShe knew it was not a question of if she'd get cancer, but when. In June 2021, a cancerous tumor was...
Cullinan Therapeutics (NASDAQ:CGEM) Shares Gap Down to $18.88
ETF DAILY NEWS· 7 hours agoCullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) shares gapped down prior to trading on Monday . Cullinan Therapeutics shares last traded at $18.56, with a volume ...
Medicare must fund blood-based cancer screenings. NY's delegatin must act
The Journal News· 15 hours agoFinding out you or a loved one has cancer can be one of the more jarring experiences in our lives....
This man’s Father’s Day will be filled with heartfelt meaning
Deseret News via Yahoo News· 3 days agoHe was about to receive a donor heart. Because he’d kept working throughout the ordeal, he was more...
New RSV shots tied to rare nervous system disorder — should you worry?
Live Science via Yahoo News· 6 days agoThere's been some reports of Guillain-Barré syndrome in older adults who got the vaccines. But...
NY urgently needs more doctors. How a Hudson Valley hospital is answering the call
The Journal News· 1 day agoMedical Colleges. In New York, the most acute doctor shortages are spread across parts of upstate,...
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
BioPharma Dive via Yahoo Finance· 1 day agoBelharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere,...
